Caidya partners with industry-recognized suppliers to complement the suite of services we offer to our biotechnology and pharmaceutical customers.
We pride ourselves on maintaining robust relationships with our global partners while ensuring exceptional business practices are maintained.
We are proud to offer many CRO services to the highest quality standards and intentionally outsource other services to best-of-breed suppliers that offer the right complementary solution for your trial. We make outsourcing decisions based on the therapeutic area of your drug and the region of the world the trial is run, and always keep in mind your corporate goals and budget.
As part of the importance we place on transparency, we do not mark up any of our outsourced activities because they complement our business, acting as an extension of our service offering to you. Our biopharmaceutical clients have benefited from this comprehensive yet bespoke model, leaving their trials in the best of hands with Caidya and our vendor-partners.
We place immense importance on diversity and inclusion, ensuring we select and evaluate suppliers based on quantitative and qualitative criteria such as cost, technological capability, global reach, quality and pedigree.
We are constantly working to ensure that our organization, the partners that we work with, and the trials we support are run as sustainably and ethically as possible. We value environmental responsibility in our partners and factor this into selection criteria.
Caidya has an outstanding reputation for transparency, quality and fair dealing.
Together, we share the responsibility of protecting our reputation and enhancing it, and to achieve that goal, we require our partners to conduct themselves in the most ethical manner possible, adhering to ethical and legal standards which are consistent with our own code of conduct.
It is the responsibility of procurement services and the greater organization to ensure the needs of our clients are both understood and proactively met.
Therefore, in addition to the factors mentioned above, we consistently strive to:
Access the right people when and where you need them with personalized clinical services tailored to you and your trial.
Explore our news and updates as we liberate the clinical research process.
With the progress of advanced precision medicine over recent years, cell and gene therapies (CGTs) continue to develop and evolve, with their advancement and ...
With the progress of precision medicine and the ...
MORRISVILLE, N.C., November 9, 2022 – Caidya, the multi-therapeutic clinical ...